General Information of Drug (ID: DM10AUP)

Drug Name
Biphenyl-3-ylcarbamic acid cyclohexyl ester
Synonyms
565460-15-3; URB602; cyclohexyl biphenyl-3-ylcarbamate; Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate; URB-602; UNII-B8371SFA9K; CHEMBL77767; Monoacylglycerol Lipase Inhibitor, URB602; biphenyl-3-ylcarbamic acid cyclohexyl ester; B8371SFA9K; URB 602; N-Biphenyl-3-ylcarbamic acid, cyclohexyl ester; N-[1,1'-Biphenyl]-3-yl-carbamic Acid Cyclohexyl Ester; SCHEMBL4274165; Cyclohexylbiphenyl-3-ylcarbamate; CTK8C4433; DTXSID90450611; HHVUFQYJOSFTEH-UHFFFAOYSA-N; MolPort-003-850-812; EX-A1228; BCP19101; BDBM50128581; ANW-71925; ZINC13520725
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 295.4
Logarithm of the Partition Coefficient (xlogp) 4.9
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C19H21NO2
IUPAC Name
cyclohexyl N-(3-phenylphenyl)carbamate
Canonical SMILES
C1CCC(CC1)OC(=O)NC2=CC=CC(=C2)C3=CC=CC=C3
InChI
InChI=1S/C19H21NO2/c21-19(22-18-12-5-2-6-13-18)20-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,18H,2,5-6,12-13H2,(H,20,21)
InChIKey
HHVUFQYJOSFTEH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10979337
CAS Number
565460-15-3
TTD ID
D0W1OX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid amide hydrolase (FAAH) TTDP1UC NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fatty acid amide hydrolase (FAAH) DTT NO-GeName 2.65E-01 0.02 0.1
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20.